Institut Carnot CALYM

CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as Carnot Institute since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere. CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research: 2 non-profit associations: The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of lymphoma research The Lymphoma Academic Research Organisation (LYSARC),...

Lymphoma,cancer,partnership research,preclinical and clinical research,translational research,clinical research,positionning,hematology,immunology,immunotherapy,antibody,blood cancer,proof of concept,clinical assay,lymphoma collection,lymphoma biomarkers,and lymphoma models

Institut carnot calym operates in the Research services industry.

Institut carnot calym's revenue is 11m - 100m

Institut carnot calym has 11 - 50 employees.